News
News Nation on MSN58m
Nasal spray could slow down Alzheimer's progression | Elizabeth Vargas Reports
A new nasal spray was developed at a Harvard University-affiliated hospital that appears to slow down the progression of Alzheimer's disease symptoms. "It can be given with other treatments," Dr.
Over-the-counter Narcan nasal spray is expected to show up in local stores this week, the latest attempt to quell the nation's drug overdose crisis — which killed an estimated 109,000 lives last ...
ARS Pharmaceuticals is poised for a “blue sky opportunity,” in launching its epinephrine nasal spray, according to Leerink Partners.
The Food and Drug Administration has approved a new medication to treat migraine headaches. Zavzpret (zavegepant) is a nasal spray that can help provide pain relief in as little as 15 minutes in ...
Sales of Narcan nasal spray rose to $224 million in 2020, or 78% of naloxone sales in dollar terms, from 15% or $56 million in 2017, according to IQVIA Holdings Inc., which collects drug sales data.
The nasal spray "Neffy" is the first needle-free option for severe allergic reactions that the FDA has approved. The spray would be an alternative to EpiPens.
Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology, 41(3), 167-174.
A nasal spray version would be much easier to administer, she said. "I'm so disappointed that our allergic community has to continue to wait for an alternative to an injectable form of epinephrine ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Neffy, a single-dose nasal spray that can be administered into one nostril, was approved for use in adult and pediatric patients who weigh at least 66 pounds.
A nasal spray can tamp down potentially fatal reactions, a boon to the many patients in crisis who fear using EpiPens. Neffy, a new device approved by the Food and Drug Administration, is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results